Vandana Singh - Spark Newswire

1 minute read

Eisai-Biogen Seek Complete FDA Approval For Its Second Alzheimer’s Treatment

Today, 5:06 PM

The FDA has accepted Eisai Co Ltd (OTC:ESALY) and Biogen Inc’s (NASDAQ:BIIB) supplemental Biologics License Application (sBLA) for Leqembi (lecanemab-irmb) 100 mg/mL injection,…

BIIB

1 minute read

Cytokinetics Posts Aficamten Data In Patients With Thickened Heart Muscle

By Vandana Singh

Today, 5:06 PM

Cytokinetics Incorporated (NASDAQ:CYTK) presented results from Cohort 4 of REDWOOD-HCM Phase 2 trial of aficamten in patients with non-obstructive hypertrophic cardiomyopathy (nHCM). At…

CYTK

1 minute read

Esperion Long Term Data On Cholesterol Medication’s Ability To Cut Cardiovascular Risk Fails To Impress Investors

By Vandana Singh

Today, 5:06 PM

Esperion Therapeutics Inc (NASDAQ:ESPR) announced the full results from the CLEAR Outcomes trial, a global study of nearly 14,000 patients with…

ESPR

1 minute read

Data Shows Abbott’s TriClip System Superior To Other Medical Therapy In Heart Valve Disorder

By Vandana Singh

Today, 5:06 PM

Abbott Laboratories (NYSE:ABT) announced late-breaking data for the TriClip transcatheter edge-to-edge repair (TEER) system, a minimally invasive device designed specifically for…

ABT

1 minute read

CareDx Earns Stock Downgrade Amid CMS Coverage Cuts Change Thesis

By Vandana Singh

Today, 5:06 PM

Raymond James downgraded CareDx Inc (NASDAQ:CDNA) to Market Perform from Strong Buy after MolDX issued a billing and coding article severely limiting coverage…

CDNA

1 minute read

Analyst Upgrades This Radiology Stock, Expects Promising 2023 Ahead

By Vandana Singh

Today, 5:06 PM

Raymond James upgraded Radnet Inc (NASDAQ:RDNT) from Market Perform to Outperform and a price target of $30 following 4Q22 results that came in…

RDNT

1 minute read

Analyst Upgrades This Stock And Doubles Price Target On Encouraging Ibsrela Story

By Vandana Singh

Today, 5:06 PM

After the market close Thursday, Ardelyx Inc (NASDAQ:ARDX) reported Q4 FY22 Ibsrela sales of $8.7 million and $15.6 million for FY22. The…

ARDX

1 minute read

How Much Did US Government Spend On mRNA Vaccine Technology Before And During The Pandemic? The Number Can Be Surprising

By Vandana Singh

Today, 5:06 PM

The U.S. government invested at least $31.9 billion to develop, produce, and purchase mRNA COVID-19 vaccines, including sizeable…

BNTX

1 minute read

Roche, Exelixis Report Second Flop Out Of Three Trials Evaluating Cabozantinib/Atezolizumab Combo

By Vandana Singh

Today, 5:06 PM

Exelixis Inc (NASDAQ:EXEL) announced that the phase 3 CONTACT-03 study did not meet its primary endpoint of progression-free survival (PFS). CONTACT-03 is…

EXEL

1 minute read

Why Veru Stock Is Crashing Today?

By Vandana Singh

Today, 5:06 PM

The FDA declined to grant Veru Inc’s (NASDAQ:VERU) request for Emergency Use Authorization (EUA) for sabizabulin to treat hospitalized adult patients…

VERU